Gastrointestinal Cancer
Conference Coverage
Everolimus is effective across diverse patients with GI neuroendocrine tumors
Key clinical point: Everolimus reduces the risk of progression or death across subgroups of patients who have advanced, progressive neuroendocrine...
Conference Coverage
Radiolabeled somatostatin analog has good showing in midgut neuroendocrine tumors
Key clinical point: 177Lu-Dotatate appears efficacious and safe for the treatment of advanced midgut neuroendocrine tumors. Major finding: Median...
News
‘D-drugs’ linked to liver disease, cancer in HIV patients
The cumulative use of dideoxynucleoside analogues, or ‘d-drugs,’ in treatment of HIV-positive patients was independently associated with increased...
News
Nonalcoholic fatty liver disease linked to liver cancer without cirrhosis
About 13% of U.S. veterans with hepatocellular carcinoma had no evidence of preexisting cirrhosis, researchers reported in the January issue of...
News
Treatment failure reduced in Barrett’s esophagus with endoscopic mucosal resection
The use of endoscopic mucosal resection before radiofrequency ablation significantly reduced the risk for treatment failure among patients with...
News
FDA approves treatment for chemotherapy ODs, life-threatening toxicities
News
SBRT may be better than RFA for large hepatocellular carcinoma lesions
Key clinical point: Stereotactic body radiotherapy (SBRT) and radiofrequency ablation (RFA) both achieved good local control for small...
News
Study finds no benefit from lapatinib for HER2-positive gastric cancer patients
Key clinical point: Addition of lapatinib to capecitabine and oxaliplatin as first-line treatment for HER2-positive advanced gastroesophageal...
News
Readmission after esophagectomy raises mortality
Key clinical point: Patients readmitted after esophagectomy are at a greater than fourfold higher risk of death than patients who do not need...
News
Portal venous blood yielded higher levels of circulating tumor cells
Researchers detected circulating tumor cells in the portal venous blood of all patients with pancreaticobiliary cancer, but in the peripheral...